STZ
49
4
ETN
80
2
DVA
57
5
AKAM
37
2
FE
37
2
PYPL
47
6
KEY
68
3
FIS
55
9
AIG
51
-3
SNA
72
19
RHI
29
4
CB
51
-2
ADM
53
9
PFG
56
3
CI
48
-4
O
30
-3
COP
42
2
RRC
46
3
SBUX
39
2
MTB
53
3
STZ
49
4
ETN
80
2
DVA
57
5
AKAM
37
2
FE
37
2
PYPL
47
6
KEY
68
3
FIS
55
9
AIG
51
-3
SNA
72
19
RHI
29
4
CB
51
-2
ADM
53
9
PFG
56
3
CI
48
-4
O
30
-3
COP
42
2
RRC
46
3
SBUX
39
2
MTB
53
3
Financhill
Back

Verve Therapeutics 10K Form

Buy
65

VERV
Verve Therapeutics

Last Price:
$10.96
Seasonality Move:
1.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VERV News And Ratings

See the #1 stock for the next 7 days that we like better than VERV

VERV Financial Statistics

Sales & Book Value

Annual Sales: $32.3M
Cash Flow: $-29.1M
Price / Cash Flow: 0
Annual Sales: $5.33
Price / Book: 2.07

Profitability

EPS (TTM): -2.11000
Net Income (TTM): $-181M
Gross Margin: --
Return on Equity: -34.75%
Return on Assets: -26.95%

Verve Therapeutics Earnings Forecast

Key Verve Therapeutics Financial Ratios

  • The Research & Development expenses have been 632.03% of Revenue.
  • The Net Earning history of VERV is -614.59% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Verve Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VERV
Website: vervetx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.84
Quick Ratio: 9.59

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VERV Technical Analysis vs Fundamental Analysis

Buy
65
Verve Therapeutics (VERV) is a Buy

Is Verve Therapeutics a Buy or a Sell?